Probiotic Sachets for Children: NCFM and Bi-07 Explained

A probiotic sachet for children containing Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 delivers two well-studied strains in a single powdered dose. Their best-known evidence is a six-month trial in 326 pre-school children in China, in which the combination was linked to fewer fever, cough and runny nose episodes. That trial was a single study at one site, so its results are promising but need confirmation.

This guide explains what the two strains are, how a child's gut develops, what the daycare trial found and did not find, how to give a sachet, and which symptoms call for a doctor rather than a supplement.

How does a child's gut microbiome develop?

The gut of a newborn is nearly sterile at birth. Colonisation begins during delivery and feeding, and is shaped by the mode of birth, breast or formula feeding, antibiotics, siblings, pets and the home environment. In breastfed infants, bifidobacteria dominate, supported by oligosaccharides in human milk that these bacteria are specially equipped to digest.

The introduction of solid foods around six months brings a rapid increase in diversity. By about three years, the microbiome resembles an adult's in structure, though it continues to mature through adolescence. This long window of change is the reason researchers study probiotics in children separately from adults, and the reason results cannot be transferred between age groups.

Why do young children get so many infections?

Pre-school children typically have around six to eight respiratory infections a year, and more when they attend childcare. Their immune systems are meeting many viruses for the first time, and shared toys, close contact and hand-to-mouth behaviour speed up spread. Most infections are caused by viruses, are self-limiting and are not helped by antibiotics.

The link between gut bacteria and immunity is a focus of research because the gut contains a large share of the body's immune tissue. Whether a probiotic can reduce the number or severity of infections in children is therefore an active question, and the evidence is mixed across strains and studies.

What is Lactobacillus acidophilus NCFM?

NCFM is one of the most researched Lactobacillus acidophilus strains. It was isolated and developed at North Carolina State University, and its code reflects that origin. The strain is now supplied within the HOWARU range of IFF.

NCFM survives stomach acid and bile, adheres to intestinal cells, and has been studied in humans for lactose digestion, digestive symptoms in adults, immune markers and childhood respiratory illness. Its genome has been sequenced, which allows safety screening for toxin and transferable resistance genes.

What is Bifidobacterium lactis Bi-07?

Bi-07 is a strain of Bifidobacterium animalis subspecies lactis, the group usually labelled B. lactis. Bifidobacteria are strictly anaerobic bacteria that make acetic and lactic acid and are among the first colonisers of the infant gut. B. lactis strains are especially stable in dried products, which is why they appear in powders and sachets.

Bi-07 has been studied mainly in combination with NCFM, in children for respiratory illness and in adults for bloating and other functional symptoms. Studies of other B. lactis strains, such as BB-12 or HN019, cannot be applied to Bi-07.

What did the daycare trial find?

The most cited study of this combination is a randomised, double-blind, placebo-controlled trial by Leyer and colleagues, published in Pediatrics in 2009. It enrolled 326 children aged 3 to 5 years attending child care in China and ran for six months over winter.

Children were assigned to one of three groups: NCFM alone, NCFM combined with Bi-07, or placebo. Probiotics were given twice daily, for a total of about 10 billion CFU a day.

The reported results were:

Fever. The incidence of fever was lower than placebo by about 53 percent with NCFM alone and 73 percent with the combination.

Cough. The incidence of cough fell by about 41 percent with NCFM alone and 62 percent with the combination.

Runny nose. The incidence was lower by about 28 percent with NCFM alone and 59 percent with the combination.

Antibiotic use and school absence. Both probiotic groups used fewer antibiotics and missed fewer days of childcare than placebo.

These are impressive percentages, and they deserve both respect and caution. The study was at a single site in one country, in a childcare setting with a high baseline of infections, and it was supported by the strain's commercial developer. Findings of this kind need replication in other populations before they can be treated as established.

The study was detailed further in probiotics and seasonal colds in preschoolers.

What can and cannot be concluded?

It is reasonable to conclude that NCFM and Bi-07, taken for months by pre-school children in childcare, were well tolerated and associated with fewer reported symptoms in one carefully conducted trial. It is also reasonable to conclude that the combination performed better than NCFM alone.

It is not reasonable to conclude that a probiotic prevents colds in every child, that the effect applies in other settings, or that it replaces vaccination, hand hygiene and good sleep. A parent should treat any claim of immunity boosting with care. Immunity is a system and no single supplement controls it.

What do broader reviews say about probiotics and respiratory infections?

Individual trials can mislead, so systematic reviews help. A Cochrane review of probiotics for preventing acute upper respiratory tract infections, which pooled trials in children and adults, concluded that probiotics may modestly reduce the number of people who get an episode and may shorten episode length, but rated the certainty of the evidence as low. The trials used different strains, doses and durations, and many were small.

This pattern explains how to read the NCFM and Bi-07 trial. It fits a general signal that some probiotics may help some children in some settings, and it does not prove that every product acts alike. Strain-specific evidence, such as this trial, is more informative than the general class of probiotics.

What is the difference between a species, a subspecies and a strain?

A species such as Lactobacillus acidophilus is a broad group. A subspecies, such as Bifidobacterium animalis subsp. lactis, is a smaller division. A strain, such as NCFM or Bi-07, is a single isolate with its own genome and behaviour. Health effects are attached to strains. This is why a label that gives only "Lactobacillus acidophilus" cannot be linked to the daycare trial, whereas one that lists NCFM can.

What does the research show for the gut itself?

NCFM and Bi-07 together have been studied in adults with functional bowel disorders, where a randomised trial found less bloating with the combination than with placebo. The trial involved adults, so the finding is indirect for children. Evidence for digestive outcomes in children, such as colic, constipation or functional abdominal pain, with this specific pair is limited.

Mechanisms proposed for these strains are shared with other lactobacilli and bifidobacteria. They include production of lactic and acetic acids, competition for nutrients and binding sites, support of the gut barrier, and interaction with immune cells in the gut lining. These explain plausibility but do not prove effect in an individual child.

How is the product evidence checked for a children's sachet?

Parents and clinicians can ask four questions. Is every strain named with its code? Is there human research on those strains in the relevant age group? Is the CFU stated as guaranteed through the shelf life? And is the manufacturer able to supply a certificate of analysis for each batch? Evidence for a strain should be weighed separately from the quality of a given product, since a good strain in a poorly made product can still disappoint.

For NCFM and Bi-07, the strain evidence is moderate: a notable paediatric trial, adult studies of bloating, and a long record of safe use. The product evidence depends on manufacturing quality and stability testing, which the manufacturer should be able to document.

Why is two-strain pairing used?

Combining a lactobacillus with a bifidobacterium covers two groups with different habits. Lactobacilli such as NCFM are more common in the small intestine and tolerate oxygen better. Bifidobacteria such as Bi-07 are anaerobes that dominate the infant colon. In the daycare trial, the pair outperformed NCFM alone, which supports the logic of combination for these strains, though it does not prove that every combination is better than a single strain.

What is Little One's?

Little One's from ELMED Life Sciences is a paediatric probiotic sachet containing Lactobacillus acidophilus (HOWARU NCFM) and Bifidobacterium lactis (HOWARU Bi-07) at 10 billion CFU per sachet, with an 18-month shelf life. It is positioned for digestive support and immune strengthening in children, and ELMED's range information describes the kids' sachets as suitable from birth to teenage years.

The 10 billion CFU per sachet is of the same order as the daily dose used in the daycare trial. The trial, however, split the dose twice a day and used a different formulation, so the results describe the strains rather than this product.

Little One's is a nutraceutical supplement. It supports gut balance and is not intended to treat disease. The age range, dose and frequency for a particular child should come from the label and from a paediatrician, especially for babies under six months.

How do children's probiotics differ from adult ones?

Children need products matched to age and purpose. The strains in a children's sachet should have a record in children, the carriers should be suitable, and the dose and mixing method should be easy to manage. A product designed for adults may contain strains or ingredients that have not been assessed in children.

NCFM and Bi-07 have been studied in both adults and children, but different questions were asked in each group: bloating in adults and respiratory symptoms in pre-school children. A parent should look for the evidence that fits the child, not simply the strain name.

What should parents look for on the label?

Check for the strain codes, the CFU per sachet at expiry, the age range, the list of other ingredients, the storage conditions and the batch number. Sweeteners, flavours and carriers in children's powders should be listed. If a child has a milk, soy or other allergy, read the ingredients for allergens, and ask a pharmacist if anything is unclear.

How should a sachet be given to a child?

Open the sachet and empty the powder into a small amount of cool or room-temperature liquid or soft food, such as water, milk, curd or mashed fruit. Stir and give it straight away, making sure the child finishes the whole portion. Avoid hot foods and drinks, since heat harms the live cultures.

For infants, the powder can be mixed into a teaspoon of expressed breast milk or water and given with a spoon or syringe. The details and common mistakes are in how to give a probiotic sachet to a child.

When should the dose be given?

Taking probiotics with or soon after a meal may improve survival through stomach acid, and a regular time each day makes the habit easier to keep. If the child is on an antibiotic, separate the doses by two to three hours after checking with the doctor.

How long should a child take it?

For immune and digestive support, trials have lasted from a few weeks to six months. A practical approach is a defined trial of four to eight weeks with a record of symptoms. If there is no change, continuing offers little reason. Long-term use should have a purpose that a paediatrician agrees with.

Is a probiotic sachet safe for children?

Lactobacillus and Bifidobacterium probiotics have a strong safety record in healthy children, with mild wind or loose stools the commonest effects. Serious problems are rare and have occurred almost entirely in children with severe underlying illness.

Take medical advice before use if the child:

• was born prematurely or is under a few months old
• has a weakened immune system or is receiving chemotherapy
• has a central venous catheter
• has serious illness or recent major gut surgery
• has short bowel syndrome

Regulators have warned against probiotics for premature infants in neonatal units, where cases of probiotic bloodstream infection occurred. Probiotics for such babies must be chosen and supervised by the neonatal team.

How do the daily routines of a child affect gut and immune health?

Sleep, physical activity, a varied diet with plenty of fruit, vegetables and pulses, and time outdoors all affect health. Breastfeeding, where possible, supports a bifidobacteria-rich gut in infants . Vaccination, hand washing and keeping unwell children at home reduce infections. A probiotic sits on top of these foundations, not in place of them. Practical points on childcare and the microbiome are in daycare, school and the gut microbiome of children.

When should a child see a doctor?

Seek medical advice promptly for a fever in a baby under three months, a fever lasting more than three days, trouble breathing, a child who is unusually drowsy or irritable, signs of dehydration, blood in the stool, persistent vomiting, severe abdominal pain or poor weight gain. Frequent infections with poor growth, unusual infections or hospital admissions should lead to an assessment of the immune system.

For diarrhoea, oral rehydration solution is the key treatment, and probiotics are only an adjunct.

How can you judge the quality of a children's probiotic?

A trustworthy product names each strain with its code, states the CFU per sachet, lists any added ingredients such as sweeteners or carriers, gives clear mixing and storage directions, shows an expiry date and batch number, and is manufactured in a GMP Certified facility. Be wary of claims to treat or cure, and of labels that give only a species name.

Key takeaways

• NCFM and Bi-07 are well-characterised strains, and the combination has one notable paediatric trial in 326 pre-school children in China.
• That trial reported fewer fever, cough and runny nose episodes, but it was at one site, industry supported, and needs replication.
• Little One's provides both strains at 10 billion CFU per sachet with an 18-month shelf life.
• Mix a sachet with cool food or drink, give it straight away, and follow the label and your paediatrician on age and dose.
• Premature or medically fragile children need a doctor's guidance before any probiotic.